Outlook Therapeutics (OTLK) Capital Expenditures Growth (1y) (2016 - 2019)
Outlook Therapeutics (OTLK) Capital Expenditures Growth (1y) (2016 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Outlook Therapeutics |
51.13 Mn |
43.39 Mn |
-21,888.00 |
- |
| Date | Value |
|---|
| Sep 30, 2019 |
-148.38% |
| Jun 30, 2019 |
353.35% |
| Mar 31, 2019 |
-81.78% |
| Dec 31, 2018 |
-78.01% |
| Sep 30, 2018 |
5,165.95% |
| Jun 30, 2018 |
-11.04% |
| Mar 31, 2018 |
370.20% |
| Dec 31, 2017 |
5,091.17% |
| Sep 30, 2017 |
-92.70% |
| Jun 30, 2017 |
-58.26% |
| Mar 31, 2017 |
224.66% |
| Dec 31, 2016 |
-94.31% |
| Sep 30, 2016 |
-90.03% |
| Jun 30, 2016 |
-87.03% |
